Developing treatments using monoclonal antibodies to fight malaria
Official title: SBIR Topic 109: Development of Monoclonal Antibody- Mediated Interventions to Combat Malaria
Funded at Cure Systems LLC · NIH-11203270 · Data updated 2026-11-12
This study is looking for ways to create new treatments for malaria using special antibodies that can help fight the disease, and if you're interested, you might have a chance to join trials to see how safe and effective these treatments are.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cure Systems LLC NIH-funded |
| Lab location | 1 site (Newton Center, United States) |
| Project start | September 18, 2024 |
| Project end | September 17, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,500,000 |
| NIH project number | 75N93024C00084-0-9999-1 |
| Project ID | NIH-11203270 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk of malaria infection, particularly those living in endemic regions.
✕Less likely to help
Patients who are not at risk of malaria or those who have already been treated for the disease may not benefit from this research.
What this research studies
This research focuses on creating monoclonal antibody-based treatments aimed at combating malaria, a serious infectious disease caused by Plasmodium parasites. The approach involves developing specific antibodies that can target and neutralize the malaria-causing agents in the body. By leveraging advanced techniques in antibody development, the research aims to provide effective interventions that could significantly reduce malaria infections and improve patient outcomes. Patients may have the opportunity to participate in trials assessing the safety and efficacy of these new treatments.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments for malaria, potentially saving lives and reducing the burden of the disease.
How similar studies have gone: Other research has shown promise in using monoclonal antibodies for infectious diseases, indicating potential success for this approach in combating malaria.
Where this research is happening
-
Cure Systems LLC
Newton Center, United States Active
Researchers
- Principal investigator: Miller, Jacqueline — Cure Systems LLC
- Study coordinator: Miller, Jacqueline
Related research
Other NIH-funded projects on the same topics.
-
Digital malaria surveillance in Ethiopia to improve outbreak detection
A collaboration to add a malaria-specific digital module to an existing surveillance system in Africa to help detect and respond to outbreaks faster.
-
Cross-sector partnership uses digital malaria surveillance in Ethiopia
A US-based team will adapt and test a digital malaria surveillance module in SORMAS to help detect and respond to malaria outbreaks in Ethiopia.
-
Malaria control project in Western Kenya to reduce illness and deaths
A large, multi-year effort in western Kenya will help track malaria spread and test ways to prevent transmission so fewer people get sick or die.
-
Optimizing tafenoquine dose to prevent relapse of vivax malaria in Asia
A study tests the best tafenoquine dose to prevent P. vivax malaria relapse in people in East Asia and Oceania.
-
Optimizing tafenoquine dose to prevent P. vivax malaria relapses in Asia
A study to find the best single-dose tafenoquine amount to prevent relapse of P. vivax malaria in people in East Asia and Oceania.
-
Severe malaria and brain risk in children
This grant studies how severe malaria in young children can affect brain development and long-term thinking and behavior, with a focus on kids in Uganda.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.